Liposome Formulation of Fullerene-Based Molecular Diagnostic and Therapeutic Agents
Fullerene medicine is a new but rapidly growing research subject. Fullerene has a number of desired structural, physical and chemical properties to be adapted for biological use including antioxidants, anti-aging, anti-inflammation, photodynamic therapy, drug delivery, and magnetic resonance imaging...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
MDPI AG,
2013-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_e200bc85beb84a90ba3225b1357f9c0b | ||
042 | |a dc | ||
100 | 1 | 0 | |a Zhiguo Zhou |e author |
245 | 0 | 0 | |a Liposome Formulation of Fullerene-Based Molecular Diagnostic and Therapeutic Agents |
260 | |b MDPI AG, |c 2013-10-01T00:00:00Z. | ||
500 | |a 10.3390/pharmaceutics5040525 | ||
500 | |a 1999-4923 | ||
520 | |a Fullerene medicine is a new but rapidly growing research subject. Fullerene has a number of desired structural, physical and chemical properties to be adapted for biological use including antioxidants, anti-aging, anti-inflammation, photodynamic therapy, drug delivery, and magnetic resonance imaging contrast agents. Chemical functionalization of fullerenes has led to several interesting compounds with very promising preclinical efficacy, pharmacokinetic and safety data. However, there is no clinical evaluation or human use except in fullerene-based cosmetic products for human skincare. This article summarizes recent advances in liposome formulation of fullerenes for the use in therapeutics and molecular imaging. | ||
546 | |a EN | ||
690 | |a fullerene | ||
690 | |a metallofullerene | ||
690 | |a liposome | ||
690 | |a antioxidant | ||
690 | |a anti-inflammation | ||
690 | |a photosensitizer | ||
690 | |a drug delivery | ||
690 | |a molecular imaging | ||
690 | |a magnetic resonance imaging | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceutics, Vol 5, Iss 4, Pp 525-541 (2013) | |
787 | 0 | |n http://www.mdpi.com/1999-4923/5/4/525 | |
787 | 0 | |n https://doaj.org/toc/1999-4923 | |
856 | 4 | 1 | |u https://doaj.org/article/e200bc85beb84a90ba3225b1357f9c0b |z Connect to this object online. |